http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
TA 약침치료를 병행한 안전벨트로 발생한 흉부통증 환자 치험 3례
정연중 ( Yeon-joong Chung ),이윤규 ( Yun-kyu Lee ),이현종 ( Hyun-jong Lee ),김재수 ( Jae-soo Kim ) 면역약침의학회(구 대한면역약침학회) 2017 대한면역약침학회지 Vol.6 No.1
Objective : This study is to show the clinical effect of additional TA (Treat Anti-imflammation) Pharmacopuncture on thoracic pain. Method : The patients were treated using TA Pharmacopuncture, and other treatments including acupunture, moxibustion and herbal medication. The effect of treatment was measured by Numeric rating scale (NRS). Results : After treatment, NRS was gradually reduced at each case. Conclusion : These results suggest that TA Pharmacopuncture might be a possible therapeutic option for thoracic pain caused by seat belt.
만성 경항통(목부위 통증)의 도침요법, 진통제, 복합치료의 효능 및 안전성 연구
공한미 ( Han Mi Gong ),전승아 ( Seungah Jun ),정연중 ( Yeon-joong Chung ),김주란 ( Ju-ran Kim ),이정희 ( Jung Hee Lee ),이현종 ( Hyun-jong Lee ),박정아 ( Chung A Park ),김재수 ( Jae Soo Kim ) 경락경혈학회 2020 Korean Journal of Acupuncture Vol.37 No.1
Objectives : We investigated the efficacy and safety of miniscalpel acupuncture (MA) treatment combined with non-steroidal anti-inflammatory drugs (NSAIDs) for chronic neck pain (CNP) in an assessor-blinded randomized controlled pilot trial to establish a basis for larger-scale randomized controlled studies on this subject. Methods : Participants (n=36) were recruited and randomly allocated to the MA group, NSAIDs and combined treatment group. The MA group received MA three times over three weeks. The NSAIDs group was administered orally with zaltoprofen 80mg t.i.d. over three weeks. The combined treatment group received MA and zaltoprofen in the same manner as MA and NSAIDs groups. The primary outcome was pain as assessed by a visual analogue scale (VAS) and the secondary outcomes were assessed using the Neck Disability index (NDI), EuroQol 5-dimension questionnaire (EQ-5D), and Patients’ Global Impression of Change scale (PGIC). Assessments were made at week 0 (baseline), 1, 2, 3 (primary end point) during treatment and at week 7 (4 weeks after the end of treatment). Results : 35 participants completed the study. No serious adverse event occurred and blood test results were within normal limits. The improvement of VAS and NDI was significantly greater in combined and MA group than that in NSAIDs group (p<0.017). The combined group showed better outcomes in EQ-5D at visit 2 and 5, in PGIC at visit 4 than the NSAIDs group (p<0.017). No significant differences were found between combined and MA group. Conclusions : Our results suggest that both combined and MA group can be more effective in improving pain control than NSAIDs group. A large-scale clinical study is warranted to further clarify these findings.